Lumara Health

St. Louis, United States Founded: 1942 • Age: 84 yrs Acquired By AMAG Pharma
Medicines for womens health are developed by Lumara Health.

About Lumara Health

Lumara Health is a Healthcare company based in St. Louis (United States) founded in 1942, and was acquired by AMAG Pharma in September 2014. Medicines for womens health are developed by Lumara Health. Lumara Health has raised $32.55 million across 4 funding rounds from investors including Perrigo, AMAG Pharma and Edgewater Capital Partners. Lumara Health offers products and services including Health Services and Medical Devices. Its focus areas include Traditional Pharmaceuticals, Generics and Therapeutic Areas. Its legal entity is Lumara Health Inc.

Company details

Lumara Health was founded in 1942 in St. Louis, United States, and operates within the pharmaceutical sector. Focus is placed on developing medicines for womens health across life stages, with emphasis on maternal health. The flagship product, Makena, is designed to reduce premature birth risks. In September 2014, the maternal health business was acquired by AMAG Pharmaceuticals. Operations center on product development for womens wellness needs.

Key Metrics
  • Total Equity Funding
    $32.55M (USD)

    in 4 rounds

  • Latest Funding Round
    $210K (USD), Series C

    Jun 2012

  • Investors
    Perrigo

    & 2 more

  • Acquired by
    AMAG Pharma

    & 1 more

    (Sep 2014)

Products & Services of Lumara Health

Lumara Health offers a comprehensive portfolio of products and services, including Health Services and Medical Devices.

Health Services
Healthcare Services

Health consulting and medical services are provided to support patient care and industry needs

Medical Devices
Medical Equipment

Medical devices are supplied and distributed for use in healthcare settings

Funding Insights of Lumara Health

Lumara Health has successfully raised a total of $32.55M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $210 thousand completed in June 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $32.55M
  • Total Rounds 4
  • Last Round Series C β€” $210,000
  • First Round $7.55M

    (Nov 2010)

All 4 funding rounds of Lumara Health with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2012$210,000Series C––
–
Apr 2011$225MDebt – Conventional––
–
Mar 2011$32.34MSeries C––
–
Nov 2010$7.55MUnspecified––
–
Valuation history

3 investors in total: 3 institutional.

Investors in Lumara Health

Lumara Health has secured backing from 3 investors. Prominent investors backing the company include Perrigo, AMAG Pharma and Edgewater Capital Partners.

All
InvestorDescriptionFounded YearDomainLocation
APIs, OTC pharmaceuticals, and nutritional products are manufactured and distributed.
1887perrigo.comAllegan, United States
Manufacturer of anemia based products and imaging agents for cancer and CVD diagnosis
1981amagpharma.comWaltham, United States
A private equity firm focused on performance materials is operated.
edgewatercapital.comCleveland, United States
Premium access

Investor details for Lumara Health

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Lumara Health

5 dated milestones of Lumara Health across 72 years, from founding to its latest funding, stage changes and deals.

  1. Founded Lumara Health is founded.
  2. Exit Acquired by Edgewater Capital.
  3. Funding First funding round of $7.6M.
  4. Funding Latest funding round, Series C, of $210K.
  5. Exit Acquired by AMAG Pharma.

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as Lumara Health (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of generics formulations
2002Bridgewater, New Jersey, United StatesUSD 3.02 B8,300
Biosimilar therapeutics are developed for oncology and autoimmune diseases.
2010Redwood City, California, United StatesUSD 143.62 MUSD 42.17 M228
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United StatesUSD 5.1 B13,500
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Lumara Health

Lumara Health was founded in 1942 and raised its 1st funding round 68 years after it was founded.

Lumara Health is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.

Lumara Health is a funded company, having raised a total of $32.55M across 4 funding rounds to date. The company's 1st funding round was a Unspecified of $7.55M, raised on Nov 2010.

Lumara Health was founded in 1942 in St. Louis, United States, and operates within the pharmaceutical sector. Focus is placed on developing medicines for womens health across life stages, with emphasis on maternal health. The flagship product, Makena, is designed to reduce premature birth risks. In September 2014, the maternal health business was acquired by AMAG Pharmaceuticals. Operations center on product development for womens wellness needs.

Lumara Health offers Health Services and Medical Devices.

Lumara Health has 3 investors. Key investors include Perrigo, AMAG Pharma, and Edgewater Capital Partners.

Lumara Health operates through Lumara Health Inc.

Yes. Lumara Health was acquired by AMAG Pharma in September 2014.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available